When most people think about dementia, cannabis is not a typical part of the conversation. However, across clinical practice, caregiver reports, and emerging research, there is growing interest in how cannabinoid therapy may support individuals living with dementia as a tool to improve quality of life, symptom management, and daily functioning.
What Is Dementia And Why Symptom Management Matters
Dementia is not a single disease. It is a clinical syndrome that affects memory, behavior, language, and decision-making to the point that it interferes with daily life.
Conditions that fall under this umbrella include:
- Alzheimer’s disease
- Parkinson’s-related dementia
- Lewy body dementia
- Frontotemporal dementia
While some causes of cognitive decline are reversible (like vitamin deficiencies or medication effects), neurodegenerative dementias are progressive and current pharmaceutical options are often limited.
The Challenge: Polypharmacy and Limited Treatment Options
Many older adults with dementia are prescribed multiple medications to manage symptoms, such as:
- Agitation
- Anxiety
- Sleep disruption
- Pain
This often leads to polypharmacy, where five or more prescription medications are used concurrently. This has become a threat to the health of older adults by:
- Increasing the risk of drug interactions and adverse events
- Escalating healthcare costs
- Reducing overall quality of life
- Decreasing healthy life expectancy
- Increasing hospitalization rates and all-cause mortality
Why Cannabis? Understanding the Endocannabinoid System
The potential of cannabis lies in its interaction with the endocannabinoid system (ECS), which is a regulatory system involved in:
- Mood
- Sleep
- Pain signaling
- Inflammation
- Appetite
- Cell survival
As the brain ages, the ECS can become dysregulated. This contributes to:
- Increased inflammation
- Oxidative stress (“cellular wear and tear”)
- Disrupted communication between brain cells
Cannabinoids like cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) may help restore balance by:
- Reducing inflammation
- Supporting neuroprotection
- Modulating neurotransmitter signaling
What the Research Shows (So Far)
Preclinical Findings
Across numerous studies, cannabinoids have demonstrated:
- Reduced brain inflammation
- Protection against oxidative stress
- Neuroprotective effects
- Reduced amyloid plaques and tau tangles (key markers of Alzheimer’s disease)
Some models even show improved cognitive performance, depending on dose and cannabinoid type.
Real-World Patient Data
In 2019, a small study in Geneva looked at 10 female dementia patients with severe behavioral symptoms. They used a THC/CBD medication, which led to a big drop in scores measuring behavioral problems. After 2 months half of patients decreased or stopped other psychotropic medications. Caregivers noticed improvements in the patients’ quality of life, suggesting that cannabis treatments could enhance the well-being of people with dementia.
Parkinson’s disease studies with overlapping dementia symptoms likewise show promise. Published in 2023, a long-term safety study of medicinal cannabis retrospectively surveyed 152 idiopathic Parkinson’s disease patients from 2008 to 2022. Over the 1 to 3 year follow ups, the medicinal cannabis treatments appeared safe without exacerbating neuropsychiatric symptoms or detrimental effects on the progression of the disease. Additional results published in 2023 observing 69 patients with Parkinson’s disease treated with medicinal cannabis with the normal course of clinical practice showed that 87% noted to exhibit an improvement in any Parkinson’s disease symptom. The highest improvements were realized for symptoms to include cramping/dystonia, pain, spasticity, lack of appetite, dyskinesia, and tremor.
Clinical Observations
A 2022 random controlled trial surveyed 60 patients with an average age of 79.4 who received either a cannabidiol-rich oil or a placebo three times daily for 16 weeks. The cannabis oil significantly reduced agitation over placebo in patients suffering from behavioral disturbances related to dementia, with no serious adverse events observed.
Where Cannabis May Help Most in Dementia
While not disease-modifying, cannabis may support:
Cannabinoids may help regulate overstimulation and emotional distress.
Improved sleep is one of the most consistently reported benefits across several studies.
Especially relevant for older adults with coexisting conditions. Results consistently show potential reduction of concomitant opioid medication use.
When studied, results highlight that cannabis may offer protective effects in older age resulting from an endocannabinoid-mediated modulation of inflammation, immune function, and neurodegeneration.
Data on the amount of food consumed for dementia patients receiving medically observed regimens with dronabinol (a synthetic THC) showed percentage increases during the treatment period.
Safety Considerations
Cannabis is not risk-free but many side effects are dose-dependent and manageable.
Common side effects include:
- Dizziness
- Dry mouth
- Sedation
- Feeling “high” (with increased THC)
These may often be addressed by:
- Adjusting dose
- Changing cannabinoid ratios
- Using alternative cannabinoids (like CBG or CBN)
Importantly, studies so far show:
- Low rates of serious adverse effects
- High tolerability when used thoughtfully
Practical Integration: A Thoughtful Approach
If exploring cannabis for dementia, consider:
- Discussing with your current provider
- Start low, go slow
- Prioritize quality-tested products
- Consider CBD + low-dose THC combinations
And always evaluate:
- Current medications
- Underlying conditions
- Individual sensitivity
Schedule time with a Realm of Caring Care Specialist to learn more (at no cost to you).
